Sun Pharma Advanced Research Company

Rediff.com » News » Sun Pharma Advanced Research Company

News for Sun Pharma Advanced Research Company

Business

Will Tata Sons Get RBI Relief?

Tata Sons, now debt-free, has asked the RBI to drop its 'upper-layer NBFC' tag and allow it to stay private. IMAGE: Bombay House in Mumbai, the headquarters of the Tata Group. Photograph: Hitesh......

692 Stocks Move Into Bear Territory

The sharp pullback in mid and smallcap stocks signals a cooling-off period in segments that previously attracted considerable investor interest. Illustration: Dominic Xavier/Rediff.com Over......

SPARC shares surge 15%; m-cap up by Rs 1,685 cr

Stocks of Sun Pharma Advanced Research Company surged 15 per cent on Monday after the company received approval from the US health regulator for a New Drug Application (NDA). Defying a weak broader......

Ranbaxy shares jump on drug approval in US

Shares of Ranbaxy Laboratories rose more than 5 per cent after the company announced a US regulatory approval for a hypertension drug to be launched by one of its subsidiaries. The stock rose by......

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Suraksha started by funding developers for projects, and then evolved into realty angel investing. Dev Chatterjee reports. IMAGE: Suraksha Smart City - Vasai-Virar's biggest township under......

Sun Pharma Advanced Research Company

News for Sun Pharma Advanced Research Company

Will Tata Sons Get RBI Relief?

692 Stocks Move Into Bear Territory

SPARC shares surge 15%; m-cap up by Rs 1,685 cr

Ranbaxy shares jump on drug approval in US

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS